e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Mechanisms of asthma and lung inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
2D-DIGE on peripheral neutrophils of COPD: Annexin A1 high molecular weight complexes as markers for systemic inflammation in COPD
A. Lo Tam Loi, J. Langereis, C. van Aalst, R. Schweizer, J. W. Lammers, L. Ulfman, L. Koenderman (Utrecht, Netherlands)
Source:
Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Session:
Mechanisms of asthma and lung inflammation
Session type:
E-Communication Session
Number:
1729
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lo Tam Loi, J. Langereis, C. van Aalst, R. Schweizer, J. W. Lammers, L. Ulfman, L. Koenderman (Utrecht, Netherlands). 2D-DIGE on peripheral neutrophils of COPD: Annexin A1 high molecular weight complexes as markers for systemic inflammation in COPD. Eur Respir J 2010; 36: Suppl. 54, 1729
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD
Source: Eur Respir J 2004; 23: 532-537
Year: 2004
IL-33 has a nuclear distribution and is not increased in peripheral lung of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Self-reported comorbidity and C-reactive protein in patients with COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Airway neutrophilia in COPD is not associated with increased neutrophil survival
Source: Eur Respir J 2006; 28: 1163-1169
Year: 2006
High sensivity C reactive protein (HS-CRP) levels mark pulmonary and systemic inflammation in stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 337s
Year: 2006
Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Inflammatory markers in skeletal muscle of low and normal weight COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Pi3kδ expression is increased in peripheral lung macrophages in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009
The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept